MDWD vs. FTLF, CDXC, BGXX, NAII, MTEX, BTMD, ACB, MNMD, JYNT, and GNFT
Should you be buying MediWound stock or one of its competitors? The main competitors of MediWound include FitLife Brands (FTLF), ChromaDex (CDXC), Bright Green (BGXX), Natural Alternatives International (NAII), Mannatech (MTEX), biote (BTMD), Aurora Cannabis (ACB), Mind Medicine (MindMed) (MNMD), Joint (JYNT), and Genfit (GNFT). These companies are all part of the "medical" sector.
FitLife Brands (NASDAQ:FTLF) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.
2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 46.8% of MediWound shares are held by institutional investors. 61.2% of FitLife Brands shares are held by insiders. Comparatively, 9.2% of MediWound shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
FitLife Brands has a net margin of 10.05% compared to FitLife Brands' net margin of -35.94%. MediWound's return on equity of 27.17% beat FitLife Brands' return on equity.
MediWound received 388 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 62.28% of users gave MediWound an outperform vote while only 0.00% of users gave FitLife Brands an outperform vote.
MediWound has a consensus price target of $32.00, indicating a potential upside of 71.58%. Given FitLife Brands' higher probable upside, analysts plainly believe MediWound is more favorable than FitLife Brands.
FitLife Brands has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
FitLife Brands has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
In the previous week, MediWound had 2 more articles in the media than FitLife Brands. MarketBeat recorded 2 mentions for MediWound and 0 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.30 beat MediWound's score of 0.00 indicating that MediWound is being referred to more favorably in the news media.
Summary
MediWound beats FitLife Brands on 9 of the 17 factors compared between the two stocks.
Get MediWound News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MediWound Competitors List
Related Companies and Tools
